These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35173839)

  • 1. Combination therapy with artemether and enalapril improves type 1 diabetic nephropathy through enhancing antioxidant defense.
    Chen Y; Weng W; Zhang H; Rong G; Yu X; Wei Q; Shao M; Cai Y; Han P; Sun H
    Am J Transl Res; 2022; 14(1):211-222. PubMed ID: 35173839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA
    PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
    Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
    Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of
    Sanaye M; Sathyapal G; Kulkarni YA
    J Diabetes Metab Disord; 2022 Dec; 21(2):1349-1358. PubMed ID: 36404856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemether attenuates renal tubular injury by regulating iron metabolism in mice with streptozotocin-induced diabetes.
    Rong G; Cai Y; Weng W; Chen Y; Yu X; Shao M; Han P; Sun H
    Am J Transl Res; 2022; 14(9):6095-6106. PubMed ID: 36247243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of astragaloside IV and ACEi ameliorates renal injuries in db/db mice.
    Zhan H; Han P; Wang M; Wang Y; Weng W; Yu X; Yuan C; Li Y; Shao M; Sun H
    Int J Clin Exp Pathol; 2020; 13(5):827-836. PubMed ID: 32509053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.
    Jiang Y; Liu J; Zhou Z; Liu K; Liu C
    Med Sci Monit; 2018 Oct; 24():7007-7014. PubMed ID: 30278036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
    Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
    J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice.
    Zheng F; Zeng YJ; Plati AR; Elliot SJ; Berho M; Potier M; Striker LJ; Striker GE
    Kidney Int; 2006 Aug; 70(3):507-14. PubMed ID: 16775596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the impacts of zamzam water on streptozotocin-induced diabetic nephropathy in rats. In-vivo and in-vitro study.
    El Maleky W; Mahfoz AM; Osman AO; Abd El-Latif HA
    Biomed Pharmacother; 2021 Jun; 138():111474. PubMed ID: 33773466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril.
    Mostafa DK; Khedr MM; Barakat MK; Abdellatif AA; Elsharkawy AM
    Life Sci; 2021 Jan; 265():118818. PubMed ID: 33275985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of hypoxia inducible factor-1α promoted progression of diabetic nephropathy with hypertension.
    Jiao Y; Jiang H; Lu H; Yang Y; Zhang Y; Zhang K; Liu H
    Exp Ther Med; 2018 Oct; 16(4):3658-3662. PubMed ID: 30233722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
    Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
    J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.